Levacetylleucine Other names: L-acetylleucine

Chemical formula: C₈H₁₅NO₃  Molecular mass: 173.105 g/mol  PubChem compound: 70912

Active ingredient description

Levacetylleucine targets underlying processes of neurological dysfunction. Nonclinical studies demonstrated that levacetylleucine corrects energy metabolism, including improving adenosine triphosphate production.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC Group Classification
N07XX27 Levacetylleucine N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX27

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Document Type Information Source  
 AQNEURSA Granules for oral suspension MPI, EU: SmPC European Medicines Agency (EU)

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

DrugBank Drug: DB16956
KEGG Drug: D12967
PubChem Compound: 70912
RxNorm Ingredient: 2375522
UNII Identifier: E915HL7K2O
ACETYLLEUCINE, L-

Medicines

Levacetylleucine is an active ingredient of these brands:

Austria (AT)

Lithuania (LT)

United States (US)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈